OMRF, drug company settle patent lawsuit
Somewhere along the road from drug discovery to commercialization, the relationship fell part between Oklahoma Medical Research Foundation and the company that licensed its intellectual property to create the drug Soliris .
As approval of the drug by federal regulators neared in 2006, Connecticut -based Alexion Pharmaceuticals declared that the intellectual property licensed from OMRF didn't apply to Soliris.
You have selected to view an article that is older than 60 days. There are several ways to unlock access to NewsOK historical content.
Please sign in. (You might already have access)
If you are a print subscriber to The Oklahoman, activate your Digital Pass for free access.
Purchase any of The Oklahoman's digital products (digital replica, archives, iPad and smartphone apps), and access to historical NewsOK content is free.
Please sign in. (You might already have access)
If you are a print subscriber to The Oklahoman, activate your Digital Pass for free access.
Purchase any of The Oklahoman's digital products (digital replica, archives, iPad and smartphone apps), and access to historical NewsOK content is free.
